Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 31 October 1997:
Vol. 278. no. 5339, pp. 876 - 878
DOI: 10.1126/science.278.5339.876
Prev | Table of Contents | Next

Reports

Transgenic Knockout Mice with Exclusively Human Sickle Hemoglobin and Sickle Cell Disease

Chris Pászty, * Catherine M. Brion, Elizabeth Manci, H. Ewa Witkowska, Mary E. Stevens, Narla Mohandas, Edward M. Rubin

To create mice expressing exclusively human sickle hemoglobin (HbS), transgenic mice expressing human alpha -, gamma -, and beta S-globin were generated and bred with knockout mice that had deletions of the murine alpha - and beta -globin genes. These sickle cell mice have the major features (irreversibly sickled red cells, anemia, multiorgan pathology) found in humans with sickle cell disease and, as such, represent a useful in vivo system to accelerate the development of improved therapies for this common genetic disease.

C. Pászty and N. Mohandas, Human Genome Center and Department of Subcellular Structure, Lawrence Berkeley National Laboratory, 1 Cyclotron Road (MS 74-157), University of California, Berkeley, CA 94720, USA.
C. M. Brion, M. E. Stevens, E. M. Rubin, Human Genome Center, Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720, USA.
E. Manci, Centralized Pathology Unit for Sickle Cell Disease, University of South Alabama Doctors Hospital, Mobile, AL 36604, USA.
H. E. Witkowska, Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA.
*   To whom correspondence should be addressed. E-mail: c_paszty{at}csa2.lbl.gov

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Histopathology of experimentally induced asthma in a murine model of sickle cell disease.
S. D. Nandedkar, T. R. Feroah, W. Hutchins, D. Weihrauch, K. S. Konduri, J. Wang, R. C. Strunk, M. R. DeBaun, C. A. Hillery, and K. A. Pritchard (2008)
Blood 112, 2529-2538
   Abstract »    Full Text »    PDF »
Vascular dysfunction in a murine model of severe hemolysis.
A. C. Frei, Y. Guo, D. W. Jones, K. A. Pritchard Jr, K. A. Fagan, N. Hogg, and N. J. Wandersee (2008)
Blood 112, 398-405
   Abstract »    Full Text »    PDF »
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
D. K. Kaul, X. Zhang, T. Dasgupta, and M. E. Fabry (2008)
Am J Physiol Heart Circ Physiol 295, H39-H47
   Abstract »    Full Text »    PDF »
C-Reactive Protein and Interleukin-6 Are Decreased in Transgenic Sickle Cell Mice Fed a High Protein Diet.
D. R. Archer, J. K. Stiles, G. W. Newman, A. Quarshie, L. L. Hsu, P. Sayavongsa, J. Perry, E. M. Jackson, and J. M. Hibbert (2008)
J. Nutr. 138, 1148-1152
   Abstract »    Full Text »    PDF »
Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.
J. Chang, P. A. Shi, E. Y. Chiang, and P. S. Frenette (2008)
Blood 111, 915-923
   Abstract »    Full Text »    PDF »
Gene Replacement Therapy for Sickle Cell Disease and Other Blood Disorders.
T. M. Townes (2008)
Hematology 2008, 193-196
   Abstract »    Full Text »    PDF »
An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice.
S. Hartenbach, M. Daoud-El Baba, W. Weber, and M. Fussenegger (2007)
Nucleic Acids Res. 35, e136
   Abstract »    Full Text »    PDF »
Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.
R. Zennadi, B. J. Moeller, E. J. Whalen, M. Batchvarova, K. Xu, S. Shan, M. Delahunty, M. W. Dewhirst, and M. J. Telen (2007)
Blood 110, 2708-2717
   Abstract »    Full Text »    PDF »
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
L. L. Hsu, H. C. Champion, S. A. Campbell-Lee, T. J. Bivalacqua, E. A. Manci, B. A. Diwan, D. M. Schimel, A. E. Cochard, X. Wang, A. N. Schechter, et al. (2007)
Blood 109, 3088-3098
   Abstract »    Full Text »    PDF »
Correction of sickle cell disease by homologous recombination in embryonic stem cells.
L.-C. Wu, C.-W. Sun, T. M. Ryan, K. M. Pawlik, J. Ren, and T. M. Townes (2006)
Blood 108, 1183-1188
   Abstract »    Full Text »    PDF »
Humanized beta-Thalassemia Mouse Model Containing the Common IVSI-110 Splicing Mutation.
J. Vadolas, M. Nefedov, H. Wardan, S. Mansooriderakshan, L. Voullaire, D. Jamsai, R. Williamson, and P. A. Ioannou (2006)
J. Biol. Chem. 281, 7399-7405
   Abstract »    Full Text »    PDF »
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease.
E. A. Manci, C. A. Hillery, C. A. Bodian, Z. G. Zhang, G. A. Lutty, and B. S. Coller (2006)
Blood 107, 1651-1658
   Abstract »    Full Text »    PDF »
Correction of the sickle cell mutation in embryonic stem cells.
J. C. Chang, L. Ye, and Y. W. Kan (2006)
PNAS 103, 1036-1040
   Abstract »    Full Text »    PDF »
Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism.
H. C. Champion, T. J. Bivalacqua, E. Takimoto, D. A. Kass, and A. L. Burnett (2005)
PNAS 102, 1661-1666
   Abstract »    Full Text »    PDF »
Proinflammatory Cytokines and the Hypermetabolism of Children with Sickle Cell Disease.
J. M. Hibbert, L. L. Hsu, S. J. Bhathena, I. Irune, B. Sarfo, M. S. Creary, B. E. Gee, A. I. Mohamed, I. D. Buchanan, A. Al-Mahmoud, et al. (2005)
Experimental Biology and Medicine 230, 68-74
   Abstract »    Full Text »    PDF »
The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo.
S. H. Embury, N. M. Matsui, S. Ramanujam, T. N. Mayadas, C. T. Noguchi, B. A. Diwan, N. Mohandas, and A. T. W. Cheung (2004)
Blood 104, 3378-3385
   Abstract »    Full Text »    PDF »
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin.
A. Solovey, R. Kollander, A. Shet, L. C. Milbauer, S. Choong, A. Panoskaltsis-Mortari, B. R. Blazar, R. J. Kelm Jr, and R. P. Hebbel (2004)
Blood 104, 840-846
   Abstract »    Full Text »    PDF »
Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice.
K. C. Wood, R. P. Hebbel, and D. N. Granger (2004)
Am J Physiol Heart Circ Physiol 286, H1608-H1614
   Abstract »    Full Text »    PDF »
Hypoxia-induced acute lung injury in murine models of sickle cell disease.
K. A. Pritchard Jr., J. Ou, Z. Ou, Y. Shi, J. P. Franciosi, P. Signorino, S. Kaul, C. Ackland-Berglund, K. Witte, S. Holzhauer, et al. (2004)
Am J Physiol Lung Cell Mol Physiol 286, L705-L714
   Abstract »    Full Text »    PDF »
Enhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice.
J. D. Holtzclaw, D. Jack, S. M. Aguayo, J. R. Eckman, J. Roman, and L. L. Hsu (2004)
Am. J. Respir. Crit. Care Med. 169, 687-695
   Abstract »    Full Text »    PDF »
Expression of HbC and HbS, but not HbA, results in activation of K-Cl cotransport activity in transgenic mouse red cells.
J. R. Romero, S. M. Suzuka, R. L. Nagel, and M. E. Fabry (2004)
Blood 103, 2384-2390
   Abstract »    Full Text »    PDF »
Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes.
A. Turhan, P. Jenab, P. Bruhns, J. V. Ravetch, B. S. Coller, and P. S. Frenette (2004)
Blood 103, 2397-2400
   Abstract »    Full Text »    PDF »
Increased erythrocyte adhesion in mice and humans with hereditary spherocytosis and hereditary elliptocytosis.
N. J. Wandersee, S. C. Olson, S. L. Holzhauer, R. G. Hoffmann, J. E. Barker, and C. A. Hillery (2004)
Blood 103, 710-716
   Abstract »    Full Text »    PDF »
METABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICE.
S. Nagar, R. P. Remmel, R. P. Hebbel, and C. L. Zimmerman (2004)
Drug Metab. Dispos. 32, 98-104
   Abstract »    Full Text »    PDF »
Correction of a mouse model of sickle cell disease: lentiviral/antisickling {beta}-globin gene transduction of unmobilized, purified hematopoietic stem cells.
D. N. Levasseur, T. M. Ryan, K. M. Pawlik, and T. M. Townes (2003)
Blood 102, 4312-4319
   Abstract »    Full Text »    PDF »
Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease.
L. S. Kean, E. A. Manci, J. Perry, C. Balkan, S. Coley, D. Holtzclaw, A. B. Adams, C. P. Larsen, L. L. Hsu, and D. R. Archer (2003)
Blood 102, 4582-4593
   Abstract »    Full Text »    PDF »
Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation.
L. de Franceschi, A. Baron, A. Scarpa, C. Adrie, A. Janin, S. Barbi, J. Kister, P. Rouyer-Fessard, R. Corrocher, P. Leboulch, et al. (2003)
Blood 102, 1087-1096
   Abstract »    Full Text »    PDF »
Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F.
Z. Yasin, S. Witting, M. B. Palascak, C. H. Joiner, D. L. Rucknagel, and R. S. Franco (2003)
Blood 102, 365-370
   Abstract »    Full Text »    PDF »
Transgenic sickle mice have vascular inflammation.
J. D. Belcher, C. J. Bryant, J. Nguyen, P. R. Bowlin, M. C. Kielbik, J. C. Bischof, R. P. Hebbel, and G. M. Vercellotti (2003)
Blood 101, 3953-3959
   Abstract »    Full Text »    PDF »
L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease.
J. Ou, Z. Ou, D. W. Jones, S. Holzhauer, O. A. Hatoum, A. W. Ackerman, D. W. Weihrauch, D. D. Gutterman, K. Guice, K. T. Oldham, et al. (2003)
Circulation 107, 2337-2341
   Abstract »    Full Text »    PDF »
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta -globin gene transfer.
S. Rivella, C. May, A. Chadburn, I. Riviere, and M. Sadelain (2003)
Blood 101, 2932-2939
   Abstract »    Full Text »    PDF »
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
J. W. Stocker, L. De Franceschi, G. A. McNaughton-Smith, R. Corrocher, Y. Beuzard, and C. Brugnara (2003)
Blood 101, 2412-2418
   Abstract »    Full Text »    PDF »
Hemoglobinopathies.
G. F. Atweh, J. DeSimone, Y. Saunthararajah, H. Fathallah, R. S. Weinberg, R. L. Nagel, M. E. Fabry, and R. J. Adams (2003)
Hematology 2003, 14-39
   Abstract »    Full Text »    PDF »
A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.
Z. He and J. E. Russell (2002)
PNAS 99, 10635-10640
   Abstract »    Full Text »    PDF »
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm.
A. Turhan, L. A. Weiss, N. Mohandas, B. S. Coller, and P. S. Frenette (2002)
PNAS 99, 3047-3051
   Abstract »    Full Text »    PDF »
A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
L. S. Kean, M. M. Durham, A. B. Adams, L. L. Hsu, J. R. Perry, D. Dillehay, T. C. Pearson, E. K. Waller, C. P. Larsen, and D. R. Archer (2002)
Blood 99, 1840-1849
   Abstract »    Full Text »    PDF »
The hypercoagulable state in thalassemia.
A. Eldor and E. A. Rachmilewitz (2002)
Blood 99, 36-43
   Abstract »    Full Text »    PDF »
Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy.
R. Pawliuk, K. A. Westerman, M. E. Fabry, E. Payen, R. Tighe, E. E. Bouhassira, S. A. Acharya, J. Ellis, I. M. London, C. J. Eaves, et al. (2001)
Science 294, 2368-2371
   Abstract »    Full Text »    PDF »
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium.
N. M. Matsui, L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki, and S. H. Embury (2001)
Blood 98, 1955-1962
   Abstract »    Full Text »    PDF »
Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia.
K. de Jong, R. K. Emerson, J. Butler, J. Bastacky, N. Mohandas, and F. A. Kuypers (2001)
Blood 98, 1577-1584
   Abstract »    Full Text »    PDF »
Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase-neo cassette located between the murine {beta}-major and {beta}-minor globin genes.
R. M. Kaufman, Z. H. Lu, R. Behl, J. M. Holt, G. K. Ackers, and T. J. Ley (2001)
Blood 98, 65-73
   Abstract »    Full Text »    PDF »
Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia.
R. Iannone, L. Luznik, L. W. Engstrom, S. L. Tennessee, F. B. Askin, J. F. Casella, T. S. Kickler, S. N. Goodman, A. L. Hawkins, C. A. Griffin, et al. (2001)
Blood 97, 3960-3965
   Abstract »    Full Text »    PDF »
Expression, purification, and characterization of human hemoglobins Gower-1 ({zeta}2{epsilon}2), Gower-2 ({alpha}2{epsilon}2), and Portland-2 ({zeta}2{beta}2) assembled in complex transgenic-knockout mice.
Z. He and J. E. Russell (2001)
Blood 97, 1099-1105
   Abstract »    Full Text »    PDF »
Second generation knockout sickle mice: the effect of HbF.
M. E. Fabry, S. M. Suzuka, R. S. Weinberg, C. Lawrence, S. M. Factor, J. G. Gilman, F. Costantini, and R. L. Nagel (2001)
Blood 97, 410-418
   Abstract »    Full Text »    PDF »
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease.
K. A. Nath, V. Shah, J. J. Haggard, A. J. Croatt, L. A. Smith, R. P. Hebbel, and Z. S. Katusic (2000)
Am J Physiol Regulatory Integrative Comp Physiol 279, R1949-R1955
   Abstract »    Full Text »    PDF »
Induction of Human Fetal Globin Gene Expression by a Novel Erythroid Factor, NF-E4.
W. Zhou, D. R. Clouston, X. Wang, L. Cerruti, J. M. Cunningham, and S. M. Jane (2000)
Mol. Cell. Biol. 20, 7662-7672
   Abstract »    Full Text »
Lentiviral Vector Transduction of Hematopoietic Stem Cells that Mediate Long-Term Reconstitution of Lethally Irradiated Mice.
W. Chen, X. Wu, D. N. Levasseur, H. Liu, L. Lai, J. C. Kappes, and T. M. Townes (2000)
Stem Cells 18, 352-359
   Abstract »    Full Text »
New Views of Sickle Cell Disease Pathophysiology and Treatment.
W. F. Rosse, M. Narla, L. D. Petz, and M. H. Steinberg (2000)
Hematology 2000, 2-17
   Abstract »    Full Text »    PDF »
Formation of Dense Erythrocytes in SAD Mice Exposed to Chronic Hypoxia: Evaluation of Different Therapeutic Regimens and of a Combination of Oral Clotrimazole and Magnesium Therapies.
L. De Franceschi, C. Brugnara, P. Rouyer-Fessard, H. Jouault, and Y. Beuzard (1999)
Blood 94, 4307-4313
   Abstract »    Full Text »    PDF »
Altered Hematopoiesis in Murine Sickle Cell Disease.
M.-J. Blouin, M. E. De Paepe, and M. Trudel (1999)
Blood 94, 1451-1459
   Abstract »    Full Text »    PDF »
Stomatocytosis Is Absent in "Stomatin"-Deficient Murine Red Blood Cells.
Y. Zhu, C. Paszty, T. Turetsky, S. Tsai, F. A. Kuypers, G. Lee, P. Cooper, P. G. Gallagher, M. E. Stevens, E. Rubin, et al. (1999)
Blood 93, 2404-2410
   Abstract »    Full Text »    PDF »
Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb beta s-globin yeast artificial chromosome: A mouse model of sickle cell anemia.
J. C. Chang, R. Lu, C. Lin, S.-M. Xu, Y. W. Kan, S. Porcu, E. Carlson, M. Kitamura, S. Yang, L. Flebbe-Rehwaldt, et al. (1998)
PNAS 95, 14886-14890
   Abstract »    Full Text »    PDF »
Substitution of the Human beta -Spectrin Promoter for the Human Agamma -Globin Promoter Prevents Silencing of a Linked Human beta -Globin Gene in Transgenic Mice.
D. E. Sabatino, A. P. Cline, P. G. Gallagher, L. J. Garrett, G. Stamatoyannopoulos, B. G. Forget, and D. M. Bodine (1998)
Mol. Cell. Biol. 18, 6634-6640
   Abstract »    Full Text »
A Knockout of a Transgenic Mouse -- Animal Models of Sickle Cell Anemia.
R. L. Nagel (1998)
N. Engl. J. Med. 339, 194-195
   Full Text »
MOUSE MODEL FOR SICKLE CELL ANEMIA.
(1997)
Journal Watch (General) 1997, 5
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)